Company Description
Phenomix hopes to create a pharmaceutical phenomenon by investigating and discovering new treatments for immune system ailments and metabolic...
Key Phenomix Financials
| Company Type | Private - NASDAQ (GM): PHMX Proposed Main Headquarters |
|---|---|
| 2006 Sales (mil.) | $0.0 |
| 2006 Employees | 43 |
More Phenomix Financials (4 pages)
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Phenomix's competition across multiple industries
Top Phenomix Competitors
Sponsored Links
The Business Directory
Phenomix Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| CEO and Director | Laura K. Shawver | Network | E-mail |
| EVP and COO | Christopher L. (Chris) Burnley | Network | E-mail |
| President | Julie M. Cherrington | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Phenomix News
- HEPATITIS C SERINE PROTEASE INHIBITORS AND USES THEREFOR [European Patents] (06 May 2008 16:59:00 EDT)
- = CFA IPO: Calendar Of Registrations With The SEC [OsterDowJones Select] (25 Apr 2008 15:00:00 EDT)
Latest Industry Video
-
ASCO 2007 Preview (5:07)
06/01/07 8:50AM ET - Wachovia Capital Markets Senior Biotech Analyst George Farmer and Miller Tabak Pharmaceutical Analyst Les Fundleyder discuss new drugs coming out at this year's conference.